SEC EDGAR Filing Information

Form 10-Q -- Quarterly report [Sections 13 or 15(d)]

Period of Report: 2008-09-30
Filing Date Changed: 2008-11-14
Documents: 5

SEC Accession No.
0000812796-08-000038
Filing date: 2008-11-14
Accepted: 2008-11-14 16:24:00

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10-Q	dor10q3q2008.htm	619326	DOR 10Q 3Q - 2008
2	EX-31.1	certceo10q3q2008.htm	13546	CERT BY CEO 10 Q 3 Q - 2008
3	EX-31.2	certcfo10q3q2008.htm	13105	CERT BY CFO 10 Q 3 Q - 2008
4	EX-32.1	certceo906sox10q3q2008.htm	7481	CERT BY CEO 906 SOX 10 Q 3Q - 2008
5	EX-32.2	certcfo906sox10q3q2008.htm	7331	CERT BY CFO 906 SOX 10 Q 3Q - 2008

		0000812796-08-000038.txt	662400	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 081191730
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628